Ezetimibe is a lipid-lowering drug, mainly used for the treatment of hypercholesterolemia and other diseases, and its duration of use needs to be determined by the condition, with the duration of administration ranging from 4 to 23 weeks.
1.Duration of medication.
(1) At present, the drug is used for the treatment of familial hypercholesterolemia, primary hypercholesterolemia and other diseases in clinical reports, and its dosage time ranges from 4 to 23 weeks, which needs to be judged according to the comprehensive judgment of the blood cholesterol level and other factors after the use of the drug, and it is recommended that the drug is reviewed regularly after the use of the drug, so that the physician can monitor the condition and adjust the dosage regimen in a timely manner.
(2) Serious adverse reactions or contraindications should be discontinued immediately.
2. Adverse reactions: abnormal liver function, abdominal pain, diarrhea and so on.
3. Contraindications.
(1) Women during pregnancy are advised to use the drug with caution.
(2) The drug is not recommended for use in severe hepatic insufficiency.
(3) The drug is contraindicated in lactating women.
(4) The drug is contraindicated in those who are allergic to the components of the drug.
(5) It is contraindicated in active liver disease and unexplained persistent elevation of serum aminotransferases.
The drug needs to be used under the guidance of a clinician, and unauthorized use is prohibited.